Clinical correlation between the consumption of nicotine and cotinine concentrations in urine and serum by competitive enzyme-linked immunosorbent assay

Pharmacology

Volumn 72, Issue 4, 2004, Pages 254-259

  Ziegler, Ulrich E ^a   Kauczok, Jens ^a   Dietz, Ulrich Andreas ^a   Reith, H Bernd ^b   Karsten, Schmidt ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b KLINIKUM KONSTANZ   (Germany)

Author keywords

Cotinine ELISA; Nicotine metabolite; Smokers, cotinine in serum and urine

Indexed keywords

COTININE; NICOTINE;

ACCURACY; ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPOSURE; FEMALE; HUMAN; LABORATORY TEST; MALE; PASSIVE SMOKING; PRIORITY JOURNAL; RELIABILITY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SMOKING; SMOKING HABIT; URINALYSIS; VALIDATION PROCESS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COTININE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; NICOTINE; NICOTINIC AGONISTS; REPRODUCIBILITY OF RESULTS; SMOKING; SMOKING CESSATION;

EID: 8344285849     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000080381     Document Type: Article

References (36)

1. Fielding JE, Phenow KJ: Health effects of involuntary smoking. N Engl J Med 1988; 319: 1452-1460.
2. Biber A, Scherer G, Höpfner I, Adlkofer F, Heller WD, Haddow JE, et al: Determination of nicotine and cotinine in human serum and urine: An interlaboratory study. Toxicol Lett 1987;35:45-52.
3. Bjercke RJ, Cook G, Rychlik N, Gjika HB, Van Vunakis H, Langone JI: Stereospecifi c monoclonal antibodies to nicotine and cotinine and their use in enzyme-linked immunosorbent assays. J Immunol Methods 1986;90:203-213.
4. Castro A, Monji N: Nicotine enzyme immunoassay. Res Commun Chem Pathol Pharmacol 1986;51:393-404.
5. Feyerabend C, Russel MAH: A rapid gas-liquid chromatographic method for the determination of cotinine and nicotine in biological fl uids. J Pharm Pharmacol 1990;42:450-452.
6. Gariti P, Rosenthal DI, Lindell K, Hansen-Flaschen J, Shrager J, Lipkin C, et al: Validating a dipstick method for detecting recent smoking. Cancer Epidemiol Biomarkers Prev 2002;111:1123-1125.
7. Hariharan M, Van Noord T: Liquid-chromatographic determination of nicotine and cotinine in urine from passive smokers: Comparison with gas-chromatography with a nitrogen-specific detector. Clin Chem 1991;37:1276-1280.
8. Kuo HW, Yang JS, Chiu MC: Determination of urinary and salivary cotinine using gas and liquid chromatography and enzyme-linked immunosorbent assay. J Chromatogr B Analyt Technol Biomed Life Sci 2002;768:297-303.
9. James H, Tizabi Y, Taylor R: Rapid method for the simultaneous measurement of nicotine and cotinine in urine and serum by gas chromatography-mass spectrometry. J Chromatogr B Biomed Sci Appl 1998;708:87-93.
10. Baranowski J, Pochopien G, Baranowska I: Determination of nicotine, cotinine and caffeine in meconium using high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 1998;707:317-321.
11. Dempsey D, Moore C, Deitermann D, Lewis D, Feeley B, Niedbala RS: The detection of cotinine in hydrolyzed meconium samples. Forensic Sci Int 1999;102:167-171.
12. Jarvis MJ, Tunstall-Pedoe H, Feyerabend C, Vesely C, Saloojee Y: Comparison of tests used to distinguish smokers from non-smokers. Am J Public Health 1987;77:1435-1438.
13. Hammond DK, Bjercke RJ, Langone JI, Strobel HW: Metabolism of nicotine by rat liver cytochromes P-450. Assessment utilizing monoclonal antibodies to nicotine and cotinine. Drug Metab Dispos 1991;19:804-808.
14. Jacob P, Benowitz NL, Shulgin A: Recent studies of nicotine metabolism in humans. Pharmacol Biochem Behav 1988;30:249-253.
15. Machacek DA, Jiang NS: Quantifi cation of cotinine in plasma and saliva by liquid chromatography. Clin Chem 1986;32:979-982.
16. Alterman AI, Gariti P, Niedbala RS: Varying results for immunoassay screening kits for cotinine level. Psychol Addict Behav 2002;16:256-259.
17. Chen X, Wolff L, Aeppli D, Guo Z, Luan W, Baelum V, et al: Cigarette smoking, salivary/ gingival crevicular fl uid cotinine and periodontal status. A 10-year longitudinal study. J Clin Periodontol 2001;28:895.
18. Mascola MA, van Vunakis H, Tager IB, Speizer FE, Hanrahan JP: Exposure of young infants to environmental tobacco smoke: Breastfeeding among smoking mothers. Am J Public Health 1998;88:893-896.
19. Pacifici R, Altieri I, Gandini L, Lenzi A, Passa AR, Pichini S, et al: Environmental tabacco smoke: Nicotine and cotinine concentration in semen. Environ Res 1995;68:69-72.
20. Wilhem SE, Grunberg NE, Benowitz NL, Alvares AP: Effects of stress on circulating nicotine and cotinine levels in vitro nicotine metabolism in the rat. Psychopharmacology 1998;137:383-390.
21. Wald NJ, Boreham J, Bailey A, Ritchie C, Haddoow JE, Knight G: Urinary cotinine as marker of breathing other people's tobacco smoke. Lancet 1984;i:230-231.
22. Wall MA, Johnson J, Jacob P, Benowitz NL: Cotinine in the serum, saliva, and urine of nonsmokers, passive smokers, and active smokers. Am J Public Health 1988;78:699-701.
23. Knight GJ, Palomaki GE, Lea DH, Haddow JE: Exposure to environmental tobacco smoke measured by cotinine 125 I-radioimmunoassay. Clin Chem 1989;35:1036-1039.
24. Hill P, Marquardt H: Plasma and urine changes after smoking different brands of cigarettes. Clin Pharmacol Ther 1980;27:652-658.
25. Gritz ER, Baer-Weiss V, Benowitz NL, Van Vunakis H, Jarvik ME: Plasma nicotine and cotinine concentrations in habitual smokeless tobacco users. Clin Pharmacol Ther 1981;30:201-209.
26. Coultas DB, Howard CA, Peake GT, Skipper PJ, Samet JM: Discrepancies between self-reported and validated cigarette smoking in a community survey of New Mexico Hispanics. Am Rev Respir Dis 1988;137:810-812.
27. Perez-Stable EJ, Marin G, Marin BV, Benowitz NL: Misclassifi cation of smoking status by self-reported cigarette consumption. Am Rev Respir Dis 1992;45:53-57.
28. Thompson SG, Barlow RD, Wald NJ, van Vunakis H: How should the urinary cotinine concentrations be adjusted for urinary creatinine concentrations? Clin Chem Acta 1990;187:289-295.
29. Haines CF, Mahajan DK, Miljkovic D, Miljkovic M, Vesell ES: Radioimmunoassay of plasma nicotine in habituated and naive smokers. Clin Pharmacol Ther 1974;16:1083-1089.
30. Feyerabend D, Ings RMJ, Russell MAH: Nicotine pharmacokinetics and its application to intake from smoking. Br J Clin Pharmacol 1985;19:239-247.
31. Kyerematen GA, Vesell ES: Metabolism of nicotine. Drug Metab Rev 1991;23:3-41.
32. Lawson GM, Hurt RD, Dale LC, Offord KP, Croghan IT, Schroeder DR, et al: Application of urine nicotine and cotinine excretion rates to assessment of nicotine replacement in light, moderate and heavy smokers undergoing transdermal therapy. J Clin Pharmacol 1998;38:510-516.
33. Kyerematen GA, Morgan Ml, Chattopadhyay B, De Bethizy JD, Vesell ES: Disposition of nicotine and eight metabolites in smokers and non-smokers: Identifi cations in smokers of two metabolites that are longer lived than cotinine. Clin Pharmacol Ther 1990;48:642-651.
34. Haley NJ, Sepkovic DW, Hoffmann D: Elimination of cotinine from body fl uids: Disposition in smokers and nonsmokers. Am J Public Health 1989;79:1046-1048.
35. Benowitz NL, Kuyt F, Jacob P, Jones RT, Osman Al: Cotinine disposition and effects. Clin Pharmacol Ther 1983; 34: 604-611.
36. Jarvis MJ, Russell MAH, Benowitz NL, Feyerabend C: Elimination of cotinine from body fl uids: Implications for non-invasive measurements of tobacco smoke exposure. Am J Public Health 1988;78:696-698.